Cite
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors.
MLA
Sperduto, Paul W., et al. “Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors.” International Journal of Radiation Oncology, Biology, Physics, vol. 114, no. 1, Sept. 2022, pp. 60–74. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2022.03.020.
APA
Sperduto, P. W., De, B., Li, J., Carpenter, D., Kirkpatrick, J., Milligan, M., Shih, H. A., Kutuk, T., Kotecha, R., Higaki, H., Otsuka, M., Aoyama, H., Bourgoin, M., Roberge, D., Dajani, S., Sachdev, S., Gainey, J., Buatti, J. M., Breen, W., & Brown, P. D. (2022). Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors. International Journal of Radiation Oncology, Biology, Physics, 114(1), 60–74. https://doi.org/10.1016/j.ijrobp.2022.03.020
Chicago
Sperduto, Paul W., Brian De, Jing Li, David Carpenter, John Kirkpatrick, Michael Milligan, Helen A. Shih, et al. 2022. “Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors.” International Journal of Radiation Oncology, Biology, Physics 114 (1): 60–74. doi:10.1016/j.ijrobp.2022.03.020.